[go: up one dir, main page]

BE901601A - 1 ALPHA, 25-DIHYDROXY-22 Z-DESHYDROVITAMINE D. - Google Patents

1 ALPHA, 25-DIHYDROXY-22 Z-DESHYDROVITAMINE D.

Info

Publication number
BE901601A
BE901601A BE0/214412A BE214412A BE901601A BE 901601 A BE901601 A BE 901601A BE 0/214412 A BE0/214412 A BE 0/214412A BE 214412 A BE214412 A BE 214412A BE 901601 A BE901601 A BE 901601A
Authority
BE
Belgium
Prior art keywords
dihydroxy
alpha
deshydrovitamine
vitamin
dehydrovitamin
Prior art date
Application number
BE0/214412A
Other languages
French (fr)
Inventor
Luca H F De
H K Schnoes
R R Sicinski
Y Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BE901601A publication Critical patent/BE901601A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Un nouveau dérivé de la vitamine D, à savoir la 1 alpha 25-dihydroxy-22Z- déshydrovitamine D2 (I) Ce composé qui se distingue par une aptitude extremement élevée à augmenter les taux sériques de calcium, est donc préféré pour remplacer la vitamine D ou ses métabolites dans le traitement des affections osseuses comme le rachitisme et l'ostéomalacie et dans d'autres applications connues.A new vitamin D derivative, namely 1 alpha 25-dihydroxy-22Z- dehydrovitamin D2 (I) This compound, which is distinguished by an extremely high ability to increase serum calcium levels, is therefore preferred to replace vitamin D or its metabolites in the treatment of bone conditions such as rickets and osteomalacia and in other known applications.

BE0/214412A 1984-01-30 1985-01-29 1 ALPHA, 25-DIHYDROXY-22 Z-DESHYDROVITAMINE D. BE901601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57511484A 1984-01-30 1984-01-30

Publications (1)

Publication Number Publication Date
BE901601A true BE901601A (en) 1985-05-17

Family

ID=24299012

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214412A BE901601A (en) 1984-01-30 1985-01-29 1 ALPHA, 25-DIHYDROXY-22 Z-DESHYDROVITAMINE D.

Country Status (11)

Country Link
JP (1) JPS61501147A (en)
AU (1) AU587174B2 (en)
BE (1) BE901601A (en)
CH (1) CH665835A5 (en)
DE (2) DE3590021C2 (en)
DK (1) DK437685A (en)
FR (1) FR2558828B1 (en)
GB (1) GB2153358B (en)
IE (1) IE57936B1 (en)
NL (1) NL8520009A (en)
WO (1) WO1985003300A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3590020T1 (en) * 1984-01-30 1986-01-23 Wisconsin Alumni Research Foundation, Madison, Wis. Unsaturated 1-hydroxyvitamin D compounds in the side chain
NL8520021A (en) * 1984-03-05 1986-02-03 Wisconsin Alumni Res Found 1-ALPHA-HYDROXYVITAMINE D2 ANALOGA AND METHOD FOR PREPARING THAT.
DE3687377T2 (en) * 1985-01-17 1993-04-29 Wisconsin Alumni Res Found VITAMIN-D-COMBINATIONS AND THEIR PRODUCTION METHOD.
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
DE3064789D1 (en) * 1979-02-15 1983-10-20 Teijin Ltd New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same

Also Published As

Publication number Publication date
DK437685D0 (en) 1985-09-27
FR2558828B1 (en) 1987-11-20
WO1985003300A1 (en) 1985-08-01
CH665835A5 (en) 1988-06-15
AU587174B2 (en) 1989-08-10
AU3837285A (en) 1985-08-09
JPS61501147A (en) 1986-06-12
GB2153358A (en) 1985-08-21
GB8502161D0 (en) 1985-02-27
GB2153358B (en) 1987-07-22
IE57936B1 (en) 1993-05-19
DK437685A (en) 1985-09-27
DE3590021C2 (en) 1992-09-10
DE3590021T (en) 1986-01-23
JPH0455425B2 (en) 1992-09-03
NL8520009A (en) 1985-12-02
IE850213L (en) 1985-07-30
FR2558828A1 (en) 1985-08-02

Similar Documents

Publication Publication Date Title
MA23355A1 (en) TRICYCLIC SULFONAMIDE COMPOUNDS USEFUL FOR INHIBITING THE G PROTEIN FUNCTION
TNSN87033A1 (en) TOLUNITRILES SUBSTITUTED BY DESα - HETEROCYCLES
DZ2103A1 (en) (Methylsulfonyl) phenyl-2- (5H) -furannones and as cox-2 inhibitors.
DE69418639D1 (en) Sulfonate and carbamate derivatives of 3-aroyl-benzo (beta) thiophenes
KR890011837A (en) Didehydro Vitamin D₃ Derivative
FR2430412A1 (en) SUBSTITUTED PROPANOLAMINE DERIVATIVES USEFUL AS MEDICAMENTS AND PROCESS FOR THEIR PREPARATION
FR2378523A1 (en) ACNE TREATMENT MEDICINE
AU623454B2 (en) Method of treating epithelial disorders
WO1979000853A1 (en) Medicine for circulatory organ
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
BE901603A (en) ISOMERS OF HYDROXYVITAMIN D2.
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
BE901601A (en) 1 ALPHA, 25-DIHYDROXY-22 Z-DESHYDROVITAMINE D.
AU580822B2 (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
TNSN86004A1 (en) PHARMACEUTICALLY ACTIVE COMPOUND AND PROCESS FOR ITS PREPARATION
FR2384756A1 (en) NEW PROCESS FOR THE PREPARATION OF MICROCRYSTALLINE VITAMIN ACETATE
FR2429783A1 (en) NEW D VITAMIN DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
FR2418241A1 (en) ALKYLTHIO (ET ARYLTHIO) -17 ANDROSTENO (17A, 16A-B) BENZOPYRANNONES-3 AND (16A, 17A-B) NAPHTOPYRANNONES-3, USEFUL AS ANTI-INFLAMMATORY
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
FR2376829A1 (en) REFRACTORY ALUMINOUS CEMENT AND ITS PREPARATION PROCESS
EP0177121A3 (en) Pharmaceutical dioxane derivatives
FR2376863A1 (en) DETERMINATION OF 1A, 25-DIHYDROXYCHOLECALCIFEROL
GB1451403A (en) Silver salt containing image receiving material
ES2002015A6 (en) [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters.
BE901602A (en) 1-UNSATURATED SIDE CHAIN HYDROXYVITAMINS.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WISCONSIN ALUMNI RESEARCH FOUNDATION

Effective date: 19960131